The average one-year price target for Nautilus Biotechnology (NasdaqCM:NAUT) has been revised to $4.08 / share. This is an ...

Tivic Health Systems is developing immune‑modulating therapies for conditions, such as radiation exposure, while expanding ...

The average one-year price target for MAIA Biotechnology (NYSEAM:MAIA) has been revised to $12.38 / share. This is an increase of 18.16% from the prior estimate of $10.48 dated February 21, 2026. The ...

Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology ...

Incubate Founder and Executive Director John Stanford spent a busy day on Capitol Hill this week making the case that the ...

Shares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than ...

1.1a Congress must establish a National Biotechnology Coordination Office (NBCO) within the Executive Office of the President with a director, appointed by the President, who would coordinate ...

The longevity biotechnology industry is rapidly evolving with the amount of academic funding and venture investment increasing at the exponential pace. Over thirty longevity startups and approximately ...

Do you want to be at the forefront of the rapidly growing biotechnology field? Do you want to develop products derived from living organisms and biomolecules? Do you have a passion for biochemistry, ...

Claflin University is building a biotech innovation center to offer students hands-on experiences in emerging fields, backed by $17 million in federal funding.

Curative Biotechnology, Inc. (OTC: CUBTD) ("Curative” or the "Company”), a development-stage biomedical company focused on novel treatments for degenerative eye diseases, today announced a reverse ...